The Synthetic Biology Revolution: How SHERLOCK Can Rapidly Detect and Diagnose Disease
AACC 2018 plenary speaker, Professor James Collins, provides an insight into the future of synthetic biology and CRISPR-based diagnostic tools
AACC 2018 plenary speaker, Professor James Collins, provides an insight into the future of synthetic biology and CRISPR-based diagnostic tools
Researchers from University of Manchester and Salford Royal NHS Foundation Trust have developed an instrument which could treat chronic ulcers with light
Perkin Elmer, Inc. launches new products to advance the management of AAV
Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab
Discover how 3D models of glioblastoma using patient-derived stem cells could enable more effective treatment
Gently compressed stacks of graphene form sharp crinkles that carry an electric charge, which could be useful in nanoscale self-assembly and other applications
New solar-powered supercapacitor could help make future wearable technologies lighter and more energy-efficient
Natural sources of the toxic form of chromium appear in wells that provide drinking water to a large population in California, offering a new perspective on California’s groundwater management challenges
Watch the product launch video for more information
Drug conjugate combines Avacta’s Affimer technology with conjugates developed at Tufts for precision delivery
Performing more than just as immune responders, the understudied glial cells, the microglia, regulate synaptic connectivity during development and disease
University of Tennessee researchers test capability of new Lu-mini luminometer during glacial analysis
The Accu-Chek Solo micropump integrates with Roche's digital health solutions for a more effective and personalized diabetes management
Malvern Panalytical unveils the new multipurpose X-ray diffraction platform at EPDIC16
The new instrument aims to offer a highly versatile recapping system to enhance user experiences
AMSBIO has announced an exosome isolation, manufacturing, and characterization service to enable R&D groups to accelerate their discovery and development activities